CD86 and bacterial infectious disease: These studies identify MHV68-induced myeloid reprogramming, characterized by the induction of MHC II in LPMs and CD86 induction in SPMs, consistent with virus-induced alterations to the PerC previously associated with MHV68-induced cross-protection against bacterial infection (Barton et al., 2007).